Pulmonary manifestations of inflammatory bowel disease: Case presentations and review

Journal of Crohn's and Colitis

Volumn 4, Issue 4, 2010, Pages 390-397

  Basseri, Benjamin ^a   Enayati, Pedram ^a   Marchevsky, Alberto ^a   Papadakis, Konstantinos A ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

5 ASA; Crohn's disease; Inflammatory bowel disease (IBD); Pulmonary manifestations; Ulcerative colitis

Indexed keywords

MESALAZINE;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENTERITIS; FEMALE; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; IRITIS; LOEFFLER PNEUMONIA; LUNG DISEASE; LUNG PARENCHYMA; MALE; ORGANIZING PNEUMONIA; PLEURISY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM;

ADOLESCENT; ADULT; BRONCHIOLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; CRYPTOGENIC ORGANIZING PNEUMONIA; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFLAMMATORY BOWEL DISEASES; LUNG; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; YOUNG ADULT;

EID: 77957313219     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.03.008     Document Type: Article

References (24)

1. Rankin G.B., Watts H.D., Melnyk C.J., et al. National Cooperative Crohn's Disease Study: extra-intestinal manifestations and perianal complications. Gastroenterology 1979, 77:914-920.
2. Veloso F., Carvalho J., Magro F. Immune-related manifestations of inflammatory bowel disease: a prospective study of 792 patients. J Clin Gastroenterol. 1996, 23:29-34.
3. Storch I., Sachar D., Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm bowel dis. 2003, 9:104-115.
4. Black H., Mendoza M., Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007, 131:524-532.
5. Pascualo-Iledo J., Calvo-Bonachera J., Carrasco-Miras, et al. Interstitial pneumonitis due to mesalamine. Ann Pharmacother. 1997, 31:499.
6. Wang K., Bowyer B., Fleming C., et al. Pulmonary infiltrates and eosinophilia associated with sulfasalazine. Mayo Clin Proc 1984, 59:343-346.
7. Sviri S., Gafanovich I., Kramer M., et al. Mesalamine induced hypersensitivity pneumonitis. J Clin Gastroenterol. 1997, 24:34-36.
8. Sigvaldason A., Sorenson S. Interstitial pneumonia due to sulfasalazine. Eur J Respir Dis. 1983, 64:229-233.
9. Fishman's pulmonary diseases and disorders 1998, 838. McGraw Hill, New York, 1133-4, 1024-5. 3rd ed. A. Fishman, J. Fishman, M. Grippi (Eds.).
10. Fiegenberg D., Weiss H., Kirshman H. Migraptory pneumonia with eosinophilia associated with sulfonamide administration. Arch Intern Med 1967, 120:85-89.
11. Ward H., Fisher K., Waghray R., et al. Constrictive bronchiolitis and ulcerative colitis. Canadian Respiratory Journal. 1999, 6:197-199.
12. Higenbottam T., Cochrane G., Clark T., et al. Bronchial disease in ulcerative colitis. Thorax 1980, 35:581-585.
13. Garg K., Lynch D.A., Newell J.D. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging. 1993, 8:159.
14. Spira A., Grossman R., Balter M. Large airway disease associated with inflammatory bowel disease. Chest. 1998, 113:1723.
15. Camus P., Piard F., Ashcroft T., et al. The lung in inflammatory bowel disease. Medicine 1993, 72:151-183.
16. Kuzela L., Vavrecka A., Prikazska M., et al. Pulmonary complications in patients with inflammatory bowel disease. Hepatogastroenterology 1999, 46:1714.
17. Tzanakis N., Bouros D., Samiou M., et al. Lung function in patients with inflammatory bowel disease. Respir Med 1998, 92:516-522.
18. Marvisi M., Borrello P.D., Brianti M., et al. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000, 16:965-968.
19. Heatley R., Thomas P., Prokipchuk E., et al. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med. 1982, 51:241-250.
20. Traverela V., Rodrigues H., Aguiar M. Bronchiolotis obliterans in ulcerative colitis. J Clin Gastroenterol. 1994, 19:339-341.
21. Hotermans G., Benard A., Guenanen H., et al. Nongranulomatous interstitial lung disease in Crohn's disease. Eur Respir J 1996, 9:380-382.
22. Hardarson S., LaBrecque D., Mitros F. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. Clin Microbiol Immunol. 1993, 99:277-281.
23. Kasuga I., Yanagisawa N., Takeo C., et al. Multiple pulmonary nodules in association with pyoderma gangrenosum. Respir Med 1997, 91:493-495.
24. Wen Z., Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?. Clin Developmental Immunology. 2004, 11:195-204.